Consortium ignores analysts in Merck offer

A buyout consortium has bid below analyst predictions for the generic drugs unit of Merck following a number of mis-valuations of the healthcare sector in recent weeks.

The group, consisting of Apax Partners and Bain Capital, has offered only just over €4bn ($5.5bn) for the pharmaceuticals company after analysts at Credit Suisse predicted that anything lower than €4.6bn would be surprising.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump